CXC, a Mexican platform specialized in private credit, completed a Series A funding round of $32.6 million, led by Kaszek. Non-bank companies like Mercado Libre, Kavak, and Stori have found this platform key for their financing. CXC's co-CEOs, Marvin Palavicini and Eduardo Etchegaray, have led a transformation since its acquisition in 2018 that allowed the company to manage over $9 billion in assets under administration.
Access to funding is an increasing challenge for Multiple Purpose Financial Companies (Sofomes). This financing is crucial for expanding operations in Latin America, the United States, and developing advanced technology. Martín Pustilnick, CEO of MUNDI, highlighted the importance of this type of financing to seize business opportunities in international markets.
Mexican companies face barriers that prevent them from applying for loans, affecting their growth and competitiveness. The lack of bank credits and dependence on investors seeking high returns make loans more expensive for clients. It is crucial that Sofomes strengthen their development to access international funds that not only provide capital but also improve transparency and governance.
Avanza Sólido is one of the few companies in Mexico to obtain B Corporation certification, aligning it with inclusive and sustainable business models, giving it greater support in the market. MUNDI, specialized in financing exporting companies in Mexico, launched a new product, Purchase Order Advances (AOC), to provide immediate liquidity to companies and support their production processes.
Solunion, the joint venture between MAPFRE and Allianz Trade, has been a strategic ally in protecting accounts receivable and managing commercial risk. José Ramón Alegre, global CEO of Solunion, celebrated the company's 10 years in Mexico and projected to expect more than 300 million pesos in 2024. Over the years, Solunion has been crucial for companies facing the risk of non-payment in a market where eight out of ten companies encounter it.
The pharmaceutical and regulatory sector anticipates improvements with Armida Zúñiga Estrada at the helm of Cofepris, focusing on streamlining and optimizing key processes. The acceleration of new medicine approvals is one of the most important challenges to combat the shortages that have affected the health sector and consumers.
